Arieska Ann SoenartaPeera BuranakitjaroenYook Chin ChiaChen Huan ChenJennifer NailesSatoshi HoshideHuynh Van MinhSungha ParkJinho ShinSaulat SiddiqueJorge SisonGuru Prasad SogunuruApichard SukonthasarnJam Chin TayBoon Wee TeoYuda TuranaNarsingh VermaTzung Dau WangYu Qing ZhangJi Guang WangKazuomi KarioUniversity Medicine and Pharmacy, Hue UniversityDe La Salle Health Sciences InstituteSunway UniversityHanyang University Medical CenterJichi Medical UniversityYonsei University Health SystemShanghai Jiao Tong University School of MedicineMadras Institute of Orthopaedics and Traumatology HospitalsKathmandu UniversityUniversity of the East Ramon Magsaysay Memorial Medical CenterFatima Memorial HospitalUniversitas Katolik Indonesia Atma JayaUniversitas IndonesiaUniversity of MalayaFuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical CollegeYong Loo Lin School of MedicineNational Taiwan University College of MedicineKing George's Medical UniversityFaculty of Medicine, Siriraj Hospital, Mahidol UniversityNational Yang-Ming University, School of MedicineTan Tock Seng HospitalChiang Mai University2020-03-262020-03-262020-01-01Journal of Clinical Hypertension. (2020)17517176152461752-s2.0-85078773011https://repository.li.mahidol.ac.th/handle/20.500.14594/53886© 2020 Wiley Periodicals, Inc. Cardiovascular Disease (CVD) is the leading cause of deaths worldwide, contributing to about 30% of all deaths. Half of the cases of CVD are estimated in Asia, the world's most populous continent. Hypertension, a major modifiable risk factor for CVD, results in more deaths than any other CV risk factors in the Asian regions. The total number of patients with hypertension is likely to grow as the population ages. The proportion of the elderly population aged 65 years or more in Asia is expected to increase from 7.4% in 2015 to 10.9% in 2030. It is important to note that more than half (54%) of the world's population live in Asia. Aside of being the biggest single risk factor for global deaths, hypertension is also an important precursor and most common risk factor of heart failure (HF). An increase in HF prevalence is clearly related to the rapid epidemiological transition caused by changes in lifestyle in Asian countries. However, the availability of data on HF burden and health care delivery is limited in Asia compared with Europe and North America. This reality has driven the working group of Asian experts for example the HOPE Asia Network to concentrate on hypertension as risk factors for CVD, with the mission to improve the management of hypertension resulting in organ protection toward a goal of achieving “ZERO” CV event in Asia. This paper aims to give an overview regarding the heart problems caused by hypertension in Asia, focus on HF.Mahidol UniversityMedicineReviewSCOPUS10.1111/jch.13753